相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence
Audrey Coilly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetic Interaction Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Cyclosporine and Tacrolimus in Healthy Volunteers
Ellen Hulskotte et al.
HEPATOLOGY (2012)
Review and management of drug interactions with boceprevir and telaprevir
Jennifer J. Kiser et al.
HEPATOLOGY (2012)
EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE
A. Coilly et al.
JOURNAL OF HEPATOLOGY (2012)
USE OF TELAPREVIR PLUS PEG INTERFERON/RIBAVIRIN FOR NULL RESPONDERS POST OLT WITH ADVANCED FIBROSIS/CHOLESTATIC HEPATITIS C
P. Kwo et al.
JOURNAL OF HEPATOLOGY (2012)
Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
Yvon Calmus et al.
JOURNAL OF HEPATOLOGY (2012)
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
Tarik Asselah et al.
LIVER INTERNATIONAL (2012)
Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice
Christophe Hezode
LIVER INTERNATIONAL (2012)
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation
Robert J. Fontana et al.
LIVER TRANSPLANTATION (2012)
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV- Positive Liver Allograft Recipients
Ulf Neumann et al.
JOURNAL OF TRANSPLANTATION (2012)
Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database
W. D. Irish et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Interleukin-28B Polymorphisms Are Associated With Histological Recurrence and Treatment Response Following Liver Transplantation in Patients With Hepatitis C Virus Infection
Michael R. Charlton et al.
HEPATOLOGY (2011)
Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus
Varun Garg et al.
HEPATOLOGY (2011)
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C
Goeran B. Klintmalm et al.
LIVER TRANSPLANTATION (2011)
PHOENIX: A Randomized Controlled Trial of Peginterferon Alfa-2a Plus Ribavirin as a Prophylactic Treatment After Liver Transplantation for Hepatitis C Virus
Natalie Bzowej et al.
LIVER TRANSPLANTATION (2011)
Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
Takasuke Fukuhara et al.
GASTROENTEROLOGY (2010)
Liver Stiffness Identifies Two Different Patterns of Fibrosis Progression in Patients with Hepatitis C Virus Recurrence After Liver Transplantation
Jose A. Carrion et al.
HEPATOLOGY (2010)
The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
Udayan Chatterji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Worse Recent Efficacy of Antiviral Therapy in Liver Transplant Recipients with Recurrent Hepatitis C: Impact of Donor Age and Baseline Cirrhosis
Marina Berenguer et al.
LIVER TRANSPLANTATION (2009)
Predictors of Sustained Virological Response After Antiviral Treatment for Hepatitis C Recurrence Following Liver Transplantation
Matteo Cescon et al.
LIVER TRANSPLANTATION (2009)
Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term Outcome
Nazia Selzner et al.
TRANSPLANTATION (2009)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
E. Xirouchakis et al.
JOURNAL OF VIRAL HEPATITIS (2008)
The natural history of recurrent hepatitis C and what influences this
Edward J. Gane
LIVER TRANSPLANTATION (2008)
Hepatitis C Virus Therapy in Liver Transplant Recipients: Response Predictors, Effect on Fibrosis Progression, and Importance of the Initial Stage of Fibrosis
Bruno Roche et al.
LIVER TRANSPLANTATION (2008)
Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
Francesco Paolo Picciotto et al.
JOURNAL OF HEPATOLOGY (2007)
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: A review and quantitative analysis
C. S. Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
Marina Berenguer et al.
LIVER TRANSPLANTATION (2006)
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression
M Berenguer et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
A Blasco et al.
HEPATOLOGY (2006)
Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
N Chalasani et al.
HEPATOLOGY (2005)
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
AK Shergill et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up
UP Neumann et al.
TRANSPLANTATION (2004)
Long-term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK Liver Transplantation Database
M Charlton et al.
LIVER TRANSPLANTATION (2004)
Preemptive therapy for hepatitis C virus after living-donor liver transplantation
Y Sugawara et al.
TRANSPLANTATION (2004)
Host and donor risk factors before and after liver transplantation that impact HCV recurrence
M Berenguer
LIVER TRANSPLANTATION (2003)
Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4
MH Wali et al.
LIVER TRANSPLANTATION (2003)
Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution
A Zekry et al.
LIVER TRANSPLANTATION (2003)
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:: A randomized study
D Samuel et al.
GASTROENTEROLOGY (2003)
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
M Berenguer et al.
HEPATOLOGY (2002)
Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
Hepatitis C virus kinetics during and immediately after liver transplantation
M Garcia-Retortillo et al.
HEPATOLOGY (2002)
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment
V Mazzaferro et al.
TRANSPLANTATION PROCEEDINGS (2001)
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
M Berenguer et al.
HEPATOLOGY (2000)
分享论文
